Eric Lefkofsky Discusses Data, Genetics and Precision Medicine at Giving Pledge Learning Session

MEDIA COVERAGE

02/21/2017

In order to accelerate research and improve the treatment options for patients diagnosed with cancer, Eric Lefkofsky, co-founder and CEO of Tempus, discusses why a data-driven approach must be part of the solution. (February 21, 2017)